Table 1.

Testing Capacity and Vaccination Rate for Selected Sample Countries, November 24, 2021, by Income Level and Inclusion in the Paxlovid-MPP Deal for Affordable Access

Income	Country	MPP	New Diagnoses (7/12/21)	Tests: Pop [1, 2]	AVG	Vaccination Rate, % [3]
LICs	Afghanistana	Yes	23	1: 52	1: 72	8.7
	Chada		0	1: 115		0.4
	Haitia		0	1: 88		0.6
	Malawia		18	1: 45		3.1
	Nigera		8	1: 134		1.9
MICs	Paraguaya	Yes	43	1: 4	1: 6.0	37
	Ugandaa		19	1: 24		1.9
	Nigeriaa		107	1: 60		1.8
	South Africa		13 147	1: 3		24
	Indonesia		261	1: 5		34
	Russia	No	31 096	2: 1	1: 2.0	40
	Thailand		3614	1: 5		61
	Brazil		10 250	1: 3		63
	Mexico		752	1: 11		50
	Iraq		625	1: 3		11
HICs	US	No	107 642	2: 1	2.4: 1	58
	UK		45 691	5: 1		70
	France		59 019	2: 1		70
	China		94	1: 9		75
	Italy		15 756	2: 1		73

Inclusions based on “most impacted” as per Statista [13] or L/MIC status. Ratios given to nearest integer.

Abbreviations: HICs, high-income countries; L/MIC, low- or middle-income country; LICs, low-income countries; MICs, middle-income countries; MPP, Medicines Patent Pool.

Worldometer data [13].